CONMED Corp — Director's Dealing 2018

Jan 4, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2018-01-02

Reporting Person: Garner Todd W. (Executive Vice President & CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-02	Options To Purchase Common Stock	$50.61	A	48000	Acquired	2028-01-02	Common Stock (48000)	Direct
2018-01-02	Rsus (restricted Stock Units)	$0	A	8000	Acquired	2028-01-02	Common Stock (8000)	Direct

Footnotes

F1: Each Stock Option represents a contingent right to receive one share of common stock, par value $0.001, per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (20%) over a five year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018.

F2: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.001 per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (25%) over a four year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018.